Document:

<PAGE>
                                                                   Exhibit 10.27

                      ALION SUBORDINATED WARRANT AGREEMENT

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE SECURITIES LAWS. THEY MAY NOT
BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A
REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE
SECURITIES ACT AND UNDER ANY RELEVANT STATE LAWS OR AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

Warrant No. __________

Cusip # __________

      THIS ALION SUBORDINATED WARRANT AGREEMENT ("Agreement" or "Warrant
Agreement") is made as of this ___ day of _________, 2002 (the "Effective
Date"), between Alion Science and Technology Corporation, a Delaware corporation
(the "Company"), Alion Science and Technology Corporation Employee Ownership,
Savings and Investment Trust (the "Trust") (for the purposes of Sections 6, 7,
15 and 17 through 26 of this Agreement only) and Randy Crawford, an individual
("Crawford").

      WHEREAS, the Company and Crawford have entered into an Employment
Agreement dated _________, 2002 (the "Employment Agreement"), pursuant to which
the Company has agreed to issue to Crawford warrants to purchase shares of the
Company's $0.01 par value per share common stock ("Common Stock").

      NOW, THEREFORE, in consideration of the premises set forth above, the
covenants, representations and warranties contained in this Agreement, and for
other good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties hereto agree as follows:

     Section 1.        Grant of Warrant.

      (a) Grant. Upon the terms and subject to the conditions hereinafter set
forth, the Company hereby grants to Crawford, or his permitted registered
transferees (subject to the restrictions set forth herein), an irrevocable right
(the "Warrant") to purchase up to [_____________ (___)] shares of Common Stock
upon exercise of the Warrant, subject to adjustment pursuant to Section 1(b)
below (the "Shares"), at an exercise price of $10 per share (the "Exercise
Price"), and to exercise the other rights, powers and privileges hereinafter set
forth. The Exercise Price and the number of Shares shall be subject to
adjustment from time to time as provided in Section 3 hereof.

      (b) Reduction in the Number of Shares Subject to the Warrant. Upon the
termination of Crawford's employment by the Company without cause (as described
in Section 17.C of the Employment Agreement) or by Crawford with Good Reason (as
defined in Section 17.A of the
<PAGE>
Employment Agreement), the number of shares subject to the Warrant shall be
reduced by an amount equal to the product of (i) the number of Shares (as
originally defined in Section 1(a) above, and (ii) the quotient of (x) the
number of whole months remaining from the date of termination of Crawford's
employment until the eighth anniversary of the Effective Date, divided by (y)
ninety-six.

      Section 2. Duration and Exercise of Warrant. Subject to Sections 2(b), 4,
5, 6 and 7 herein, the parties hereto agree as follows,

      (a) Subject to the remaining provisions of this Agreement, the Warrant may
be exercised, in whole or in part, by Crawford and/or his permitted transferees
(Crawford and his permitted transferees are hereinafter referred to individually
or collectively as the "Holder") on any business day on or after the Effective
Date and through and including (i) the date that is thirty (30) days following
the date of the Company's delivery to the Holder of the appraisal performed by
an independent appraiser at the Company's request in connection with the Alion
Science and Technology Corporation Employee Ownership, Savings and Investment
Plan (the "ESOP") that sets forth the per share value of the Common Stock as of
September 30, 2010 (the "September 2010 Appraisal"), if the ESOP is still in
existence on September 30, 2010 and if none of clauses (a), (b) and (c) of the
definition of "Current Market Price" in Section 3(c)(ii) below are applicable;
provided that the September 2010 Appraisal shall not reflect any discount for
any lack of liquidity or absence of control, or (ii) the eighth (8th)
anniversary of the Effective Date, if the ESOP is not still in existence on
September 30, 2008 or if one of the clauses (a), (b) or (c) of the definition of
"Current Market Price" in Section 3(c)(ii) below is applicable (in each case,
the "Expiration Date"). At 5:00 P.M., Eastern Standard Time, on the Expiration
Date, the Warrant shall be and become void and of no value to the extent it has
not been exercised prior to such time.

      (b) The Holder shall not be entitled to exercise any portion of the
Warrant unless it has delivered written notice in the form of the Form of
Election to Purchase attached hereto as Exhibit A (the "Exercise Notice") to the
Company in accordance with Section 15 of this Warrant Agreement ninety (90) days
prior to the proposed effective date of such exercise. Subject to the terms of
Sections 2(h) and 7(b), the Warrant or a portion thereof, as appropriate, shall
be deemed to be exercised ninety (90) days from the date (the "Exercise Date")
the Company receives the Exercise Notice.

      (c) The Holder shall make payment for the exercise of the Warrant, or a
portion thereof, as appropriate, in the form of cash, or in lieu of cash, the
Holder may elect to receive such number of Shares equal to the value (as
determined below) of the exercised Warrant, or portion thereof, by indicating in
the Exercise Notice the Holder's desire to consummate a cashless exercise
("Cashless Exercise Notice"), in which event the Company shall issue to the
Holder a number of Shares computed using the following formula:

                                    Y  x  ( A - B )
                           X  =    ------------------
                                           A

                                       2
<PAGE>
Where:

      X=    The number of Shares to be issued to the Holder;

      Y=    The number of Shares purchasable under the Warrant if exercised in
            full, or the exercised portion thereof, as appropriate;

      A=    The then current Fair Value (as determined in accordance with
            Section 3(c) herein); and

      B=    The then current Exercise Price.

      (d) Upon exercise of any portion of the Warrant and payment of the
Exercise Price therefor, the Company shall issue to the Holder stock
certificates representing the shares of Common Stock underlying such exercised
portion of the Warrant, or representing such number of Shares as computed in
accordance with Section 2(c) above, as appropriate.

      (e) If this Warrant is exercised in respect of less than all of the Shares
at the time purchasable hereunder, the Holder hereof shall be entitled to
receive a new Warrant covering the number of Shares in respect of which this
Warrant shall not have been exercised and setting forth the aggregate Exercise
Price applicable to such shares, in which case the Holder shall at the same time
surrender this Warrant to the Company for cancellation.

      (f) The Shares issuable upon the exercise of this Warrant by the Holder
under this Section 2 shall be deemed to have been issued to the Holder at the
Exercise Date, and the Holder shall be deemed for all purposes to have become
the record holder of such Shares at the Exercise Date.

      (g) The Company shall not close its books against the transfer of this
Warrant or of any Share issued or issuable upon the exercise of this Warrant in
any manner which interferes with the timely exercise of this Warrant.

      (h) Notwithstanding any other provision hereof, if an exercise of any
portion of this Warrant is to be made in connection with a public offering, a
Drag-Along Notice (as defined in Section 6), a Tag-Along Notice (as defined in
Section 7), or a sale of the Company, the exercise of any portion of this
Warrant (and the payment of the Exercise Price related thereto) shall be
conditioned upon the consummation of the public offering, the transaction which
is the subject of such Drag-Along Notice or Tag-Along Notice, or such sale of
the Company in which case such exercise shall not be deemed to be effective
until the concurrent consummation of such transaction.

      (i) The Company shall pay all reasonable expenses, taxes (excluding
transfer taxes) and other charges payable in connection with the preparation,
execution and delivery of stock certificates pursuant to this Section,
regardless of the name or names in which such stock certificates shall be
registered. Such stock certificates shall be delivered within five (5) days of
the applicable Exercise Date.

      (j) The Company will at all times prior to the Expiration Date reserve and
keep available such number of authorized shares of its Common Stock, solely for
the purpose of issue

                                       3
<PAGE>
upon the exercise of the rights represented by this Warrant as may at any time
be issuable upon the exercise of this Warrant and such shares issuable upon the
exercise of this Warrant shall at no time have an aggregate par value which is
in excess of the aggregate Exercise Price.

      (k) The Company may at its option issue fractional Shares, or cash
representing the then current Fair Value of such fractional Shares, upon any
exercise of this Warrant, if appropriate.

      Section 3. Adjustment of Number of Shares and Exercise Price.

      The number of shares of Common Stock underlying the Warrant and the
Exercise Price shall be subject to adjustment from time to time as follows in
each applicable instance. With respect to any determination of adjustments to
the number of shares of Common Stock or the Exercise Price which may be required
by this Section 3, the Company's board of directors shall make a good faith
determination regarding any adjustment.

      (a) In the event of any change in the outstanding Common Stock of the
Company due to stock dividends, consolidations, stock splits or reverse stock
splits, the number of shares of Common Stock underlying the Warrant and/or the
Exercise Price will be appropriately adjusted, upwards or downwards, so that the
Holder thereafter shall be entitled to purchase the number of shares of Common
Stock consistent with such change at an exercise price that is proportionate
with such change.

      (b) If the Company issues or sells any Additional Stock (as defined in
Section 3(l) below) for a consideration less than Fair Value (as defined in
Section 3(c) herein) as of the date of execution of the binding written
agreement providing for such issuance or sale, the Exercise Price for the
Warrant which was in effect immediately prior to each such issuance shall be
reduced to the "Diluted Price". The Diluted Price shall be calculated in
accordance with the following formula for any issuance of Additional Stock in a
transaction triggering the rights afforded in this Section 3(b) (the "Trigger
Transaction"). The product of the per share consideration and the number of
shares of Additional Stock issued in connection with the corresponding Trigger
Transaction shall hereinafter be referred to as the "Transaction Price".

      The Diluted Price shall equal the product of (i) the Exercise Price
(subject to adjustment pursuant to this Section 3) and (ii) the quotient of (x)
the number of then outstanding shares of Common Stock on a fully diluted basis
(assuming the exercise of all outstanding options, rights (including, without
limitation, stock appreciation rights ("SARs")) and warrants and the conversion
into Common Stock of all convertible securities) plus the number of shares of
Additional Stock that would have been issued for the Transaction Price if the
per share consideration in the Trigger Transaction had been equal to the Fair
Value per Share as of the date of execution of the binding written agreement
providing for the issuance of the Additional Stock, divided by (y) the number of
then outstanding shares of Common Stock on a fully diluted basis (assuming the
exercise of all outstanding options, rights and warrants and the conversion into
Common Stock of all convertible securities) plus the number of shares of
Additional Stock issued in connection with the Trigger Transaction.

      (c) Fair Value and Current Market Price.

                                       4
<PAGE>
            (i) The "Fair Value", at any given time, shall mean the fair value
of the appropriate security (including, without limitation, any share of Common
Stock), property, assets, business or entity as determined in good faith by the
board of directors of the Company. Notwithstanding the foregoing, in the case of
any security, if clauses (a), (b) or (c) of the definition of Current Market
Price are applicable to such security, then the Fair Value of such security
shall be the Current Market Price of such security.

            (ii) "Current Market Price" of any security (including, without
limitation, any share of Common Stock) as of any date herein specified shall
mean the average of the daily closing prices for the twenty (20) consecutive
trading days immediately prior to, but not including the day in question (or in
the event that a security has been traded for less than twenty (20) days, each
of the trading days prior to the day in question on which such security has been
traded). The closing price for each day shall be (a) if such security is listed
or admitted for trading on any domestic national securities exchange, the
closing sale price of such security, regular way, or the average of the closing
bid and asked prices thereof if no such sale occurred, in each case as
officially reported on the principal securities exchange on which such security
is listed, or (b) if not reported as described in clause (a), the closing sale
price of such security, or the average of the closing bid and asked prices
thereof if no such sale occurred, in each case as reported by the Nasdaq
National Market, or any similar system of automated dissemination of quotations
of securities prices then in common use, if so quoted, as reported by any member
firm of the New York Stock Exchange selected by the Company, or (c) if not
quoted as described in clause (b), the average of the closing bid and asked
prices for such security as reported by the National Quotation Bureau
Incorporated or any similar successor organization, as reported by any member
firm of the New York Stock Exchange selected by the Company.

      (d) No adjustment of the Exercise Price shall be made in an amount less
than one cent per share, provided that any adjustments that are not required to
be made by reason of this sentence shall be carried forward and shall be taken
into account in any subsequent adjustment made after the date of the event
giving rise to the adjustment being carried forward.

      (e) Reorganization, Reclassification or Recapitalization of the Company.
If and whenever subsequent to the date hereof the Company shall effect (i) any
reorganization or reclassification or recapitalization of the capital stock of
the Company (other than in the cases referred to in Section 3(a)), (ii) any
consolidation or merger of the Company with or into another Person, (iii) the
sale, transfer or other disposition of the property, assets or business of the
Company as an entirety or substantially as an entirety or (iv) any other
transaction (or any other event shall occur) as a result of which holders of
Shares become entitled to receive any Common Stock or other securities and/or
property of the Company, any of its Subsidiaries or any other Person (including,
without limitation, cash) with respect to or in exchange for the Shares, there
shall thereafter be deliverable upon the exercise of this Warrant or any portion
thereof (in lieu of or in addition to the Shares theretofore deliverable, as
appropriate) the same number of shares of Common Stock or other securities
and/or the same amount of property (including, without limitation, cash) to
which the holder of the number of Shares which would otherwise have been
deliverable upon the exercise of this Warrant or any portion thereof at the time
would have been entitled upon such reorganization or reclassification or
recapitalization of capital stock, consolidation, merger, sale, transfer,
disposition or other transaction or upon the occurrence of such other event, and
at the same aggregate Exercise Price. The term "Person" shall mean an
individual, a corporation, an association, a joint-stock company, a business
trust or other similar

                                       5
<PAGE>
organization, a partnership, a limited liability company, a joint venture, a
trust, an unincorporated organization or a government or any agency,
instrumentality or political subdivision thereof.

      (f) Determination of Consideration. For the purposes of this Section 3,
the consideration received or receivable by the Company for the issuance, sale
or grant of shares of Common Stock, options, warrants, rights or convertible
securities, irrespective of the accounting treatment of such consideration,
shall be valued and determined as follows:

            (i) Cash Payment. In the case of cash, the gross amount paid by the
purchasers without deduction of any accrued interest or dividends, any
reasonable expenses paid or incurred and any reasonable underwriting commissions
or concessions paid or allowed by the Company in connection with such issue or
sale.

            (ii) Non-Cash Payment. In the case of consideration other than cash,
the Fair Value thereof (in any case as of the date immediately preceding the
issuance, sale or grant in question).

            (iii) Certain Allocations. If shares of Additional Stock are issued
or sold together with other securities or other assets of the Company for a
consideration which covers more than one of the foregoing categories of
securities and assets, the consideration received or receivable (computed as
provided in Sections 3(f)(i) and 3(f)(ii)) shall be allocable to such shares of
Additional Stock as reasonably determined in good faith by the board of
directors of the Company (provided such allocation is set forth in a written
resolution and a certified copy thereof is furnished to the Holder of this
Warrant promptly (but in any event within thirty (30) days following its
adoption).

            (iv) Dividends in Securities. If the Company shall declare a
dividend or make any other distribution upon the Common Stock of the Company
payable in shares of Additional Stock, such shares of Additional Stock, as the
case may be, issuable in payment of such dividend or distribution shall be
deemed to have been issued or sold without consideration.

            (v) Rights and Convertible Securities. The consideration for which
each share of Additional Stock shall be deemed to be issued upon the execution
of the binding written agreement providing for the issuance or sale of any
Additional Stock shall be determined by dividing (A) the total consideration, if
any, received by the Company as consideration for the Additional Stock, as the
case may be, plus the minimum aggregate amount of additional consideration, if
any, ever payable to the Company upon the exercise of such Additional Stock, as
the case may be, but without deduction of any accrued interest or dividends, any
reasonable expenses paid or incurred and any reasonable underwriting commissions
or concessions paid or allowed by the Company in connection with such issue or
sale; by (B) the maximum number of shares of Common Stock issuable upon the
exercise of such Additional Stock or attributable to such Additional Stock.

            (vi) Merger, Consolidation or Sale of Assets. If any shares of
Additional Stock are issued in connection with any merger or consolidation of
which the Company is the surviving corporation, the amount of consideration
therefor shall be deemed to be the Fair Value of such portion of the assets and
business of the non-surviving corporation as shall be attributable to such
Additional Stock, as the case may be.

                                       6
<PAGE>
      (g) Shares Outstanding. The number of shares of Common Stock deemed to be
outstanding at any given time shall not include shares of Common Stock held by
the Company or any Subsidiary of the Company, but shall include shares of Common
Stock held by or in the name of the ESOP or any trust associated with the ESOP.

      (h) Maximum Exercise Price. At no time shall the Exercise Price exceed the
amount set forth in Section 1 of this Warrant except as a result of an
adjustment thereto pursuant to this Section 3.

      (i) Application. All subdivisions of this Section 3 are intended to
operate independently of one another. If a transaction or an event occurs that
requires the application of more than one subdivision, all applicable
subdivisions shall be given independent effect (but without duplication of
adjustment).

      (j) INTENTIONALLY OMITTED.

      (k) Effect of Failure. Failure to give any certificate or notice, or any
defect in any certificate or notice required under this Section 3 shall not
affect the legality or validity of the adjustment of the Exercise Price or the
number of Shares purchasable upon exercise of this Warrant.

      (l) "Additional Stock" shall mean any shares of Common Stock, warrants or
rights (including, without limitation, SARs) to purchase Common Stock, or
securities convertible into Common Stock, issued or deemed to have been issued
by the Company, other than:

            (i) SARs issued to employees, consultants, officers or directors of
the Company or any of its Subsidiaries with an exercise price no less than Fair
Value, except for such amount of SARs that, at the time of issuance, would cause
the aggregate number of SARs then outstanding (excluding any SARs that have (x)
been exercised, (y) expired, terminated unexercised, or become unexercisable or
(z) been forfeited or otherwise terminated, surrendered or canceled) to be in
excess of:

                  (1) two percent (2%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the first anniversary of the Effective Date;

                  (2) four percent (4%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the second anniversary of the Effective Date;

                  (3) six percent (6%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the third anniversary of the Effective Date;

                                       7
<PAGE>
                  (4) eight percent (8%) of the number of then outstanding
shares of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the fourth anniversary of the Effective Date; and

                  (5) ten percent (10%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the fifth anniversary of the Effective Date.

            (ii) shares of Common Stock contributed by the Company to any
Company benefit plan, including, but not limited to, the ESOP ("Company
Contributions"), except for such amount of shares that, at the time of issuance,
would cause the aggregate value of all Company Contributions (in each case the
total value of a Company Contribution is calculated by multiplying the number of
shares of Common Stock contributed by the Fair Value at the time of such
contribution) to exceed five percent (5%) of the Company's aggregate
consolidated payroll expenses (i.e., the aggregate payroll expenses of the
Company and any of the Company's Subsidiaries substantially all of whose
employees are eligible to participate in such Company benefit plans) from the
Effective Date to the date of such contributions, measured at the end of each
plan year for such Company benefit plans;

            (iii) shares of Common Stock issued to the ESOP in connection with
employees' purchase of ESOP interests after the Effective Date via payroll
deductions, at a purchase price which is the lesser of (x) the Fair Value as of
the date of issuance of such Common Stock as determined by an independent
appraiser in connection with the ESOP ("Full Price Employee Contributions"), or
(y) the Fair Value resulting from the immediately preceding appraisal of the
Common Stock performed by an independent appraiser in connection with the ESOP
("Price Protected Employee Contributions"), except for such amount of shares
that, at the time of issuance, would cause the aggregate value of all Price
Protected Employee Contributions (in each case the total value of a Price
Protected Employee Contribution shall be the dollar value of the payroll
deduction made in connection with such Price Protected Employee Contribution) to
exceed three percent (3%) of the Company's aggregate consolidated payroll
expenses (i.e., the aggregate payroll expenses of the Company and any of the
Company's Subsidiaries substantially all of whose employees are eligible to
participate in the ESOP) from the Effective Date to the date of such
contributions, measured at the end of each plan year for the ESOP;

            (iv) shares of Common Stock, or any other securities or property of
the Company, issued to the Holder pursuant to any of its rights or privileges
under this Agreement; and

            (v) interests or rights designated as phantom stock issued or
granted by the Company to employees, consultants, officers or directors of the
Company or any of its Subsidiaries in accordance with a phantom stock plan to be
adopted by the Company's board of directors after the Effective Date, except for
such amount of phantom stock that, at the time of issuance or grant, would cause
the aggregate number of shares of phantom stock then outstanding (excluding any
shares of phantom stock that have (x) expired, terminated unexercised, or become
unexercisable, or (y) been forfeited or otherwise terminated, surrendered or
cancelled) to be in excess of 171,494 shares of phantom stock.

                                       8
<PAGE>
      (m) In the case of the Company's contribution, after the Effective Date,
of any shares of Common Stock to any Company benefit plan, including but not
limited to the ESOP, the consideration for such shares shall be deemed to be
equal to the Fair Value of such shares on the date of contribution.

      (n) "Subsidiary" means, with respect to any Person, (i) any corporation
more than fifty percent (50%) of the outstanding securities having ordinary
voting power of which shall at the time be owned or controlled, directly or
indirectly, by such Person or by one or more of its Subsidiaries or by such
Person and one or more of its Subsidiaries, or (ii) any partnership, limited
liability company, association, joint venture or similar business organization
more than fifty percent (50%) of the ownership interests having ordinary voting
power of which shall at the time be so owned or controlled. Unless otherwise
expressly provided, all references herein to a "Subsidiary" means a Subsidiary
of the Company.

      Section 4. Call Rights.

      (a) Subject to the terms and conditions of this Section 4, the Company
shall have the following call rights with respect to the Warrant:

            (i) immediately upon receipt of any Exercise Notice from the Holder
and prior to any pending Exercise Date (as determined pursuant to Section 2(b)),
the Company shall have the right to purchase that portion of the Warrant
proposed to be exercised by the Holder pursuant to such Exercise Notice, and if
the Company exercises such right, the Holder shall be required to sell such
portion of the Warrant to the Company at a purchase price (the "Call Price")
determined in accordance with Section 4(b);

            (ii) at any time within thirty (30) days following (a) the date of
the Company's delivery to the Holder of the appraisal performed by an
independent appraiser at the Company's request in connection with the ESOP that
sets forth the per share value of the Common Stock as of September 30, 2009 (the
"September 2009 Appraisal"), if the ESOP is still in existence on September 30,
2009 and none of clauses (a), (b) and (c) of the definition of "Current Market
Price" in Section 3(c)(ii) below are applicable, or (b) the seventh (7th)
anniversary of the Effective Date, if the conditions of clause (b) above are not
met (in either case, the "First Put/Call Date"), the Company shall have the
right to purchase up to fifty percent (50%) of the Warrant from the Holder, and
if the Company exercises such right, the Holder shall be required to sell up to
fifty percent (50%) of the Warrant to the Company at the Call Price determined
in accordance with Section 4(b) below; and

            (iii) at any time within thirty (30) days prior to the Expiration
Date, the Company shall have the right to purchase up to one hundred percent
(100%) of the Warrant from the Holder, and if the Company exercises such right,
the Holder shall be required to sell the Warrant or any portion thereof, as the
case may be, to the Company at the Call Price determined in accordance with
Section 4(b) below.

      (b) The "Call Price" is equal to the product of (i) the number of shares
of Common Stock underlying the Warrant or the portion thereof being purchased
pursuant to this Section 4, and (ii) the difference between the Call Fair Value
(as defined below) on the date of the Call Notice (as defined below) and the
current Exercise Price on the date of the Call Notice; provided

                                       9
<PAGE>
that notwithstanding the foregoing, in no event shall the Call Price be less
than zero (0). So long as the ESOP is still in existence, the "Call Fair Value"
shall equal (i) the per share value of the Common Stock as set forth in the then
most recent appraisal performed by an independent appraiser at the Company's
request in connection with the ESOP, for the purposes of the Company's call
right under Section 4(a)(i), (ii) the per share value of the Common Stock as set
forth in the September 2009 Appraisal, for the purposes of the Company's call
right under Section 4(a)(ii), and (iii) the per share value of the Common Stock
as set forth in the September 2010 Appraisal, for the purposes of the Company's
call right under Section 4(a)(iii). As of such date that the ESOP is no longer
in existence, the "Call Fair Value" shall equal the Fair Value of the Common
Stock. Notwithstanding the foregoing, whether or not the ESOP is in existence,
if clauses (a), (b) or (c) of the definition of Current Market Price are
applicable to the Common Stock but no Qualified Public Offering (as defined
below) has occurred, then the Call Fair Value shall be the Current Market Price
of the Common Stock on the date of the Call Notice.

      (c) Prior to exercising its call rights under this Section 4, the Company
must deliver written notice to the Holder (the "Call Notice"), in accordance
with Section 15, of its intent to purchase the Warrant or the portion thereof
being purchased, as the case may be. The Call Notice shall be deemed to be given
and served on the date that the Company sends the Call Notice to the Holder (the
"Call Election Date") and shall be irrevocable.

      (d) Payment of the Call Price shall be made in cash in immediately
available funds within thirty (30) days after the date of the Call Election
Date, but not later than the Exercise Date.

      (e) If the Company has received an Exercise Notice from the Holder prior
to the Company's delivery of a Call Notice to the Holder, then such Call Notice
shall take priority over such Exercise Notice until the expiration of the dates
set forth in Section 4(d). If the Company does not purchase the portion of the
Warrant subject to the Call Notice on or prior to the appropriate date set forth
in Section 4(d), the Holder shall be entitled to immediately exercise the
portion of the Warrant it originally intended to exercise, without the delivery
of any additional Exercise Notice, subject to the expiration of the ninety-day
period following delivery of the Exercise Notice.

      (f) If the Holder has received a Tag-Along Notice from the Trust in
accordance with Section 7(a) herein prior to delivery by the Company to the
Holder of a Call Notice and the Holder has responded to such Tag-Along Notice
with a Participation Notice and an Exercise Notice in accordance with Section
7(b) herein, then the Company shall not be entitled to exercise its call right
pursuant to Section 4(a)(i), Section 4(a)(ii) or Section 4(a)(iii) herein with
respect to such portion of the Warrant to be exercised by the Holder in
connection with such Participation Notice, unless (i) the Call Fair Value as of
the date of delivery by the Company of a Call Notice is greater than or equal to
the per share sale price in connection with the transaction that is the subject
of the Tag-Along Notice or the transaction that is subject of the Tag-Along
Notice has been terminated.

      (g) The rights of the Company under this Section 4 shall expire on the
consummation by the Company of a Qualified Public Offering. For purposes of this
Agreement, "Qualified Public Offering" means the consummation of one or more
underwritten public offerings of the Company's Common Stock which results in
aggregate gross proceeds to the sellers in such

                                       10
<PAGE>
offerings of not less than U.S. $30,000,000 (excluding proceeds received in such
offerings from "affiliates" of the Company (other than any Holder that is an
affiliate of the Company), within the meaning of Rule 12b-2 of the Securities
and Exchange Commission under the Securities Act of 1934, as amended (the
"Exchange Act") or the ESOP) and pursuant to which the Company obtains a listing
for its shares on a United States national securities exchange, the Nasdaq
National Market System, or an automated quotation system of nationally
recognized standing.

      Section 5. Put Right.

      (a) Subject to the terms and conditions of this Section 5 and Section 6
below, the Holder shall have the following put rights with respect to the
Warrant:

            (i) at any time within thirty (30) days following the First Put/Call
Date, the Holder shall have the right to sell up to fifty percent (50%) of the
Warrant to the Company, and if the Holder exercises such right, the Company
shall be required to purchase up to fifty percent (50%) of the Warrant from the
Holder for a purchase price (the "Put Price") determined in accordance with
Section 5(b) below; and

            (ii) at any time within thirty (30) days prior to the Expiration
Date, the Holder shall have the right to sell up to one hundred percent (100%)
of the Warrant to the Company, and if the Holder exercises such right, the
Company shall be required to purchase the Warrant, or such portion thereof, as
the case may be, from the Holder for the Put Price.

      (b) The "Put Price" is equal to the product of (i) the number of shares of
Common Stock underlying the Warrant or the portion thereof being purchased
pursuant to this Section 5, and (ii) the difference between the Put Fair Value
(as defined below) on the date of the Put Notice (as defined below) and the
Exercise Price on the date of the Put Notice; provided that notwithstanding the
foregoing, in no event shall the Put Price be less than zero (0). So long as the
ESOP is in existence, the "Put Fair Value" shall equal (i) the per share value
of the Common Stock as set forth in the September 2009 Appraisal, which such
appraisal shall not reflect any discount for any lack of liquidity or absence of
control, for the purposes of the Holder's put right under Section 5(a)(i), and
(ii) the per share value of the Common Stock as set forth in the September 2010
Appraisal, for the purposes of the Holder's put right under Section 5(a)(ii). As
of such date that the ESOP is no longer in existence, the "Put Fair Value" shall
equal the Fair Value of the Common Stock. Notwithstanding the foregoing, whether
or not the ESOP is in existence, if clauses (a), (b) or (c) of the definition of
Current Market Price are applicable to the Common Stock but no Qualified Public
Offering has occurred, then the Put Fair Value shall be the Current Market Price
of the Common Stock on the date of the Put Notice.

      (c) Prior to exercising its put right under Section 5(a)(i), the Holder
must deliver written notice to the Company (the "Put Notice"), in accordance
with Section 15, by July 30, 2009, of its intention to exercise its right under
Section 5(a)(i) to sell the Warrant, or any portion thereof, to the Company, and
similarly, prior to exercising its put right under Section 5(a)(ii), the Holder
must deliver the Put Notice to the Company by June 30, 2010. The Put Notice
shall be deemed to be given and served on the date that the Company receives the
Put Notice. The date that the Holder intends to exercise its put right pursuant
to either Section 5(a)(i) or Section 5(a)(ii) as indicated in the Put Notice,
shall in each case be hereinafter referred to as the "Put Exercise Date".

                                       11
<PAGE>
      (d) Payment of the Put Price shall be made in cash in immediately
available funds within ninety (90) days after the date of the Put Exercise Date
(the "Put Effective Date").

      (e) If the Company has received an Exercise Notice from the Holder prior
to receipt of a Put Notice from the Holder, then the Holder shall not be
entitled to exercise its put right pursuant to Section 5(a) herein with respect
to such portion of the Warrant that is the subject of the aforementioned
Exercise Notice.

      (f) If the Trust has sent a Drag-Along Notice to the Holder in accordance
with Section 6(a) herein in connection with a transaction that has not been
consummated or terminated prior to delivery by the Holder of a Put Notice to the
Company, then the Holder shall not be entitled to exercise its put right
pursuant to Section 5(a) with respect to any portion of the Warrant that is the
subject of such Drag-Along Notice, unless the transaction that is the subject of
the Drag-Along Notice is terminated or not consummated within sixty (60) days of
the date of the Drag-Along Notice; provided that notwithstanding the foregoing
the Holder shall be entitled to deliver a Put Notice to the Company (if
permitted under Section 5(a) prior to such termination or expiration of such
sixty (60) day period which Put Notice shall (if permitted under Section 5(a))
be given full effect upon the occurrence of such termination or expiration, but
no days that have passed from the date of delivery to the Company of the Put
Notice until the date of such termination or expiration, as appropriate, shall
be counted for purposes of the waiting periods under Sections 5(e) and 5(f).

      (g) The rights of the Holder under this Section 5 shall expire on the
consummation by the Company of a Qualified Public Offering.

      Section 6. Drag-Along Rights.

      (a) Subject to the terms and conditions of this Section 6, and
notwithstanding Section 2(b) herein, if the Trust proposes to sell seventy-five
percent (75%) or more of the shares of Common Stock it then holds (the "Drag
Sale Shares") to a bona fide unaffiliated third party or parties on an arm's
length basis in a single transaction or a series of related transactions for
either (i) cash or unrestricted marketable securities that are traded on a U.S.
stock exchange, over the counter or on a bulletin board, or (ii) any
consideration so long as the third party or parties that have proposed to
purchase the Drag Sale Shares shall not become the "beneficial owner" (as
defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or
indirectly, of more than fifty percent (50%) of the common stock of the ultimate
parent company of the Company (assuming the execution of all outstanding stock
options, stock warrants and stock rights, and conversion of all other securities
that are convertible to shares of common stock of such ultimate parent company),
or if there is no such ultimate parent company, so long as such third party or
parties shall not become the "beneficial owner", directly or indirectly of more
than fifty percent (50%) of the total outstanding Common Stock or Voting Stock
(as defined in Section 6(j) below) of the Company (assuming the execution of all
outstanding stock options, stock warrants and stock rights, and conversion of
all other securities of the Company that are convertible to shares of Common
Stock or Voting Stock), the Trust shall be entitled to provide to the Holder, at
least ten (10) days prior to the closing of such sale, written notice, in
accordance with Section 15 herein, of its good faith intention to sell the
shares of Common Stock, the name of the proposed transferee(s) (the "Proposed
Transferee"), the price and other material terms under which the sale

                                       12
<PAGE>
is proposed to be made and that it is requiring the Holder to exercise all or a
portion of the Warrant, if any portion remains outstanding and unexpired
hereunder, and to sell the Shares obtained through such exercise, if any (the
"Required Exercise Shares"), as well as a certain number of the Shares then held
by the Holder to the Proposed Transferee on the terms and conditions contained
therein ("Drag-Along Notice"), such that the total number of Shares to be sold
to the Proposed Transferee by the Holder shall be equal to:

                                   C
                  (A  +  B)  x   -----
                                   D

where:      A =   the number of Shares then held by the Holder, including the
                  Required Exercise Shares;

            B =   the number of shares of Common Stock subject to the
                  outstanding, unexpired portion of the Warrant (if any) below,
                  after taking into account the exercise required with respect
                  to the Required Exercise Shares (but excluding any portion of
                  the Warrant that is not subject to drag-along rights pursuant
                  to Section 6(f) below);

            C =   the number of Drag Sale Shares; and

            D =   the total number of shares of Common Stock then held by the
                  Trust,

subject to the limitation that if the sale price to the Proposed Transferee is
less than the then current Exercise Price, (i) the Holder shall not be required
to exercise any portion of the Warrant in order to sell to the Proposed
Transferee the Shares that could be obtained by such exercise, in connection
with the proposed sale and (ii) that portion of the Warrant which the Holder
would have been required to exercise under this Section 6 in the absence of the
preceding clause (i), shall immediately expire and shall be and become void and
of no value.

      The Holder shall be required to, and shall, comply with the terms of the
Drag-Along Notice as long as it is consistent with the terms of this Section 6.
The Shares to be sold by the Holder to the Proposed Transferee shall be sold to
the Proposed Transferee at a purchase price equal to the product of (x) the
number of such Shares, and (y) the per share sale price of the shares of Common
Stock proposed to be sold by the Trust to the Proposed Transferee. The
Drag-Along Notice shall be deemed to be given and served on the date that the
Holder receives the Drag-Along Notice from the Company in accordance with
Section 15.

      (b) Notwithstanding Section 2(b) herein and subject to Section 6(i), the
Holder shall, within five (5) days of receipt of a Drag-Along Notice, deliver an
Exercise Notice to the Company with respect to the Required Exercise Shares
provided that the Exercise Date is deemed to occur concurrently with the
consummation of the transaction which is the subject of the Drag-Along Notice.
If the Holder does not deliver the Exercise Notice within the required 5-day
period or delivers the Exercise Notice without the appropriate payment in cash
for the exercise of the Warrant, or portion thereof, as appropriate, upon
consummation of the transaction which is the subject of the Drag-Along Notice
the Holder will have been deemed to have delivered a Cashless Exercise Notice to
the Company in accordance with Section 2(c) above.

                                       13
<PAGE>
      The Company's call rights under Section 4(a)(i) shall not apply to the
Holder's exercise with respect to the Required Exercise Shares.

      (c) Promptly after receipt of the Drag-Along Notice, the Holder shall
deliver to the Trust, to hold in escrow pending closing of the transaction that
is the subject of the Drag-Along Notice, stock certificates in its possession
(if any) representing its shares of Common Stock to be transferred, properly
endorsed for transfer to the Proposed Transferee.

      (d) The Trust shall, together with the Drag-Along Notice, provide to the
Holder a fairness opinion from an independent appraiser or investment bank
selected by the Trust regarding the transaction that is the subject of the
Drag-Along Notice, provided that there shall be no such requirement if the Trust
has obtained such a fairness opinion for itself with respect to the transaction
that is the subject of the Drag-Along Notice.

      (e) The monetary value of any indemnity to be provided by the Holder to
the Proposed Transferee under the terms of its sale of Shares in accordance with
this Section 6 (which indemnity may also cover operational matters not the
subject of the Holder's representations and warranties described in the
following sentence) shall be in the same ratio to the monetary value of the
indemnity provided by the Trust as the ratio of the relative value of the
securities to be sold by each of the Holder and the Trust in any such sale, but
in no case shall it exceed the monetary value of the consideration it receives
pursuant to the terms of such sale. The Holder's representations and warranties
shall be limited to enforceability, the ownership of the Shares to be
transferred by such Holder, authority to transfer such Shares, that such Shares
are free of liens and encumbrances as of the transfer date and other standard
and customary non-operational representations and warranties.

      (f) If the Company has received a Put Notice from the Holder in accordance
with Section 5(c) herein prior to delivery by the Trust to the Holder of a
Drag-Along Notice, then the Trust shall not be entitled to exercise its
drag-along right pursuant to Section 6(a) herein with respect to such portion of
the Warrant that is the subject of such Put Notice, unless the per share sale
price in connection with the transaction that is the subject of the Drag-Along
Notice is greater than or equal to the Put Fair Value as of the date of delivery
of such Drag-Along Notice by the Trust.

      (g) If upon the Trust's delivery of a Drag-Along Notice to the Holder
there is a pending Exercise Date, Put Exercise Date and/or Put Effective Date,
then the corresponding Exercise Notice and the 90-day waiting period under the
last sentence of Section 2(b) or the corresponding Put Notice and the applicable
waiting periods under Sections 5(e) and 5(f)), as the case may be, shall be
tolled, as of the date of delivery of the Drag-Along Notice (the "Drag Toll
Date") and the Exercise Date, the Put Exercise Date and/or Put Effective Date,
as applicable, shall be suspended, and shall only be rescheduled in accordance
with Section 6(j)(i) below. The suspended Exercise Date, Put Exercise Date
and/or Put Effective Date, as applicable, and the corresponding Exercise Notice
or Put Notice, as appropriate, shall be cancelled if the transaction that is the
subject of the Drag-Along Notice is consummated within sixty (60) days of the
date of delivery of the Drag-Along Notice by the Trust to the Holder.

      (h) If the Trust delivers a Drag-Along Notice to the Holder in accordance
with Section 6(a) following its delivery of a Tag-Along Notice to the Holder in
accordance with Section 7(a), then such Tag-Along Notice, and any Participation
Notice delivered by the Holder

                                       14
<PAGE>
in connection with the Tag-Along Notice, shall be deemed cancelled and of no
effect as of the date of delivery of the Drag-Along Notice to the Holder, and
the Holder shall not be entitled to exercise such tag-along right.

      (i) Notwithstanding Section 6(b) above and subject to the limitations of
Section 2(a) above, after receiving a Drag-Along Notice, the Holder shall be
entitled to deliver to the Company an Exercise Notice relating to the portion of
the Warrant that is the subject of a Drag-Along Notice, provided that such
Exercise Notice shall only be given effect if the transaction relating to the
Drag-Along Notice is terminated or is not consummated within sixty (60) days of
the date of delivery of the Drag-Along Notice by the Trust, and further provided
that no days that have passed from the date of delivery to the Company of the
Exercise Notice until the date of such termination or expiration, as
appropriate, shall be counted for purposes of the waiting period under Section
2(b).

      (j) If the transaction that is the subject of a Drag-Along Notice
delivered by the Trust to the Holder in accordance with Section 6(a) herein (the
"Drag Transaction") is terminated or is not consummated within sixty (60) days
of the date of delivery of the Drag-Along Notice by the Trust, then

            (i) notwithstanding anything contained herein to the contrary, any
Exercise Date, Put Exercise Date and/or Put Effective Date that was/were
suspended pursuant to Section 6(g) above shall each be deemed reinstated, but no
days that have passed from the Drag Toll Date until the date of termination of
the Drag Transaction or the date as of which the above noted sixty-day period
has elapsed, as appropriate, shall be counted for purposes of the waiting
periods under Sections 2(b), 5(e) and 5(f), and the corresponding election to
exercise or put the Warrant, or portion thereof, and the corresponding Exercise
Notice or Put Notice, shall be deemed reinstated and effective subject to the
rescheduled date of the Exercise Date, the Put Exercise Date and/or Put
Effective Date, as appropriate, to reflect the provisions of this Section
6(j)(i); and

            (ii) the Drag-Along Notice shall be deemed voided.

      (j) "Voting Stock" shall mean shares of capital stock of a Person having
ordinary voting power for the election of a majority of the members of the board
of directors of such person, other than shares having such power only by reason
of the happening of a contingency (prior to the occurrence of such contingency).

      (k) The rights of the Trust under this Section 6 shall expire upon the
consummation by the Company of a Qualified Public Offering.

      Section 7. Tag-Along Rights.

      (a) Subject to the terms and conditions of this Section 7 and
notwithstanding Section 2(b) herein, if the Trust proposes to sell twenty-five
percent (25%) or more of the Shares it then holds to a bona fide unaffiliated
third party or parties on an arm's length basis in a single transaction or a
series of related transactions, and the Trust did not elect its drag-along right
pursuant to Section 6(a) above, the Trust shall provide to the Holder, at least
thirty (30) days prior to the closing of such sale, written notice, in
accordance with Section 15 herein, of its

                                       15
<PAGE>
intention to sell the shares of Common Stock, the name of the Proposed
Transferee, the price and other material terms under which the sale is proposed
to be made and that the Holder is entitled to immediately exercise a certain
portion of the Warrant, if any portion thereof is still outstanding and
unexpired hereunder, and to sell the Shares obtained through such exercise, if
any (the "Optional Exercise Shares"), as well as a certain number of the Shares
then held by the Holder to the Proposed Transferee on the terms and conditions
contained therein ("Tag-Along Notice").

      (b) Subject to the terms and conditions of this Section 7, upon receipt of
the Tag-Along Notice, the Holder shall have the right, exercisable upon written
notice in accordance with Section 15 herein to the Trust, sent within twenty
(20) days after the Holder's receipt of the Tag-Along Notice (the "Participation
Notice"), to exercise a portion of the Warrant, if still outstanding and
unexpired hereunder, and to sell to the Proposed Transferee the Optional
Exercise Shares, if any, and a certain number of Shares then held by the Holder
(collectively, the "Tag Shares"), such that in the aggregate the number of
Shares to be sold by the Holder to the Proposed Transferee shall be no greater
than:

                                      (  B  +  C )
                           A   x     --------------
                                            D

      where: A =    the number of shares of Common Stock proposed to be sold by
                    the Trust to the Proposed Transferee (the "Tag Sale
                    Shares");

      B =           the number of Shares then held by the Holder, including any
                    Optional Exercise Shares;

      C =           the number of shares of Common Stock subject to the
                    outstanding, unexpired portion of the Warrant (if any),
                    after taking into account the exercise with respect to any
                    Optional Exercise Shares (but excluding any portion of the
                    Warrant that is not entitled to the benefit of tag-along
                    rights pursuant to Section 7(e) below); and

      D =           the total number of shares of Common Stock then outstanding
                    (assuming the exercise of all outstanding options, warrants
                    and rights, and the conversion into Common Stock of  all
                    convertible securities).

      Any of the Shares sold to the Proposed Transferee shall be sold by the
Holder at the same per share price and on the same terms and conditions as
specified in the Tag-Along Notice or any modification thereof, but in no event
less favorable than the terms and conditions of Shares sold by the Trust.
Together with its delivery of the Participation Notice to the Trust, the Holder
is required to deliver an Exercise Notice to the Company with respect to the
Optional Exercise Shares. The Participation Notice shall be deemed to be given
and served on the date that the Trust receives the Participation Notice.
Notwithstanding Section 2(b) herein, the portion of the Warrant to be exercised
pursuant to the terms of this Section 7 and the Exercise Notice, shall be deemed
exercised with respect to the Optional Exercise Shares concurrently with the
consummation of the transaction which is the subject of the Tag-Along Notice as
provided in Section 2(h). If the Holder delivers the Participation Notice but
fails to deliver the appropriate

                                       16
<PAGE>
payment in cash for the exercise of the Warrant, or portion thereof, as
appropriate, at the time of consummation of such transaction, then the Holder
will have been deemed to have delivered a Cashless Exercise Notice to the
Company in accordance with Section 2(c) above. The Company's call rights under
Section 4(a)(i) shall not apply to the Holder's exercise with respect to the
Optional Exercise Shares. The Holder's failure to respond within the 20-day
period noted above shall be deemed a decision by the Holder not to participate
in such sale.

      (c) To the extent that the Holder exercises its right of participation in
accordance with the terms and conditions set forth in Section 7(b), the Proposed
Transferee may decide to purchase all of the Tag Shares, in addition to all of
the Tag Sale Shares. In the event the Proposed Transferee does not so decide,
then the number of Tag Sale Shares that the Trust may sell in the transaction
(on the same terms and conditions as specified in the Tag-Along Notice or any
modification thereof) will be reduced by the number of shares necessary to
permit the sale of the Tag Shares in accordance with the provisions of Section
7(b).

      (d) Promptly after delivery of the Participation Notice, the Holder shall
deliver to the Trust, to hold in escrow pending closing of the sale of shares of
Common Stock, stock certificates in its possession (if any) representing its
shares of Common Stock to be transferred, properly endorsed for transfer to the
Proposed Transferee. The Holder's failure to deliver the stock certificates so
endorsed by the closing date of the sale to the Proposed Transferee shall be
deemed a decision by the Holder not to participate in such transaction.

      (e) To the extent that the Proposed Transferee refuses to purchase any
portion of the Tag Shares from the Holder (the "Refused Shares"), the Trust
shall not sell to the Proposed Transferee any Tag Sale Shares unless and until,
simultaneously with such sale, the Trust shall purchase the Refused Shares from
the Holder for the same consideration per Share as specified in Section 7(b). In
such event, the number of Tag Sale Shares that the Trust may sell to the
Proposed Transferee will be increased by adding the number of shares of Common
Stock represented by the Refused Shares.

      (f) If the Company has sent a Call Notice to the Holder in accordance with
Section 4(c) herein prior to delivery by the Trust of a Tag-Along Notice to the
Holder, then the Holder shall not be entitled to exercise its tag-along right
pursuant to Section 7(b) herein with respect to such portion of the Warrant that
is the subject of the aforementioned Call Notice.

      (g) If upon the Trust's delivery of a Tag-Along Notice to the Holder there
is a pending Exercise Date, Put Exercise Date and/or Put Effective Date, then
the corresponding Exercise Notice and the 90-day waiting period under the last
sentence of Section 2(b) or the corresponding Put Notice and the applicable
waiting periods under Sections 5(e) and 5(f), as the case may be, shall be
tolled, as of the date of delivery of the Tag-Along Notice (the "Tag Toll Date")
and the Exercise Date, the Put Exercise Date and/or Put Effective Date, as
applicable, shall be suspended, and shall only be rescheduled in accordance with
Section 7(i)(i) below. The suspended Exercise Date, Put Exercise Date and/or Put
Effective Date, as applicable, and the corresponding Exercise Notice or Put
Notice, as appropriate, shall be cancelled if the transaction that is the
subject of the Tag-Along Notice is consummated within sixty (60) days of the
date of delivery of the Tag-Along Notice by the Trust to the Holder.

      (h) Notwithstanding Section 7(b) above and subject to the limitations of
Section 2(a) above, after delivering a Participation Notice to the Trust, the
Holder shall be entitled to deliver

                                       17
<PAGE>
to the Company an Exercise Notice relating to the portion of the Warrant that is
the subject of a Participation Notice, provided that the Exercise Notice shall
only be given effect if the transaction relating to the Participation Notice is
terminated or is not consummated within sixty (60) days of the date of delivery
of the corresponding Tag-Along Notice by the Trust, and further provided that no
days that have passed from the date of delivery to the Company of the Exercise
Notice until the date of such termination or expiration, as appropriate, shall
be counted for purposes of the waiting period under Section 2(b).

      (i) If the transaction that is the subject of a Tag-Along Notice delivered
by the Trust to the Holder in accordance with Section 7(a) herein (the "Tag
Transaction") is terminated or is not consummated within sixty (60) days of the
date of delivery of the Tag-Along Notice by the Trust then

            (i) notwithstanding anything contained herein to the contrary, any
Exercise Date, Put Exercise Date and/or Put Effective Date that was/were
suspended pursuant to Section 7(g) above shall each be deemed reinstated, but no
days that have passed from the Tag Toll Date until the date of termination of
the Tag Transaction or the date as of which the above noted sixty-day period has
elapsed, as appropriate, shall be counted for purposes of the waiting periods
under Sections 2(b), 5(e) and 5(f), and the corresponding election to exercise
or put the Warrant or portion thereof, and the corresponding Exercise Notice or
Put Notice, shall be deemed reinstated and effective subject to the rescheduled
date of the Exercise Date, the Put Exercise Date and/or Put Effective Date, as
appropriate, to reflect the provisions of this Section 7(i)(i); and

            (ii) the Tag-Along Notice and corresponding Participation Notice
shall be deemed voided.

      (j) The rights of the Holder under this Section 7 shall expire upon the
consummation of a Qualified Public Offering.

      Section 8. Rights as Stock.

      Notwithstanding any other rights that the Holder may have that arise out
of any stockholding in the Company, the Holder shall not be entitled to vote or
be deemed the holder of Common Stock or any other securities of the Company
which may at any time be issuable on the exercise of the Warrant, nor shall
anything contained herein be construed to confer upon the Holder, by virtue of
the Warrant, the rights of a stockholder of the Company or the right to vote
upon any matter submitted to stockholders at any meeting thereof, or give or
withhold consent to any corporate action or to receive notice of meetings or
other actions affecting stockholders (except as provided herein), or the right
to receive dividends or subscription rights or otherwise.

Section 9.        Registration of Warrants and Shares.

      Neither the Warrant nor the Shares have been registered under the
Securities Act, as amended (such Act, or any similar Federal statute then in
effect, being hereinafter referred to as the "Act").

                                       18
<PAGE>
      Section 10. Assignment of Rights and Benefits by the Holder.

      (a) Subject to the terms of Section 11 and subject to the restrictions set
out in Section 10(b), the Holder may (x) transfer the Warrant, or a portion
thereof, or (y) assign all or any portion of its rights and/or benefits under
this Agreement (each a "Warrant Transfer"), provided that,

            (i) the Company is, at least fifteen (15) days prior to such Warrant
Transfer, furnished with written notice of the name and address of the
transferee or assignee;

            (ii) the transferee agrees in writing to be bound by and subject to
the terms and conditions of this Agreement pursuant to the form of Assignment
and Joinder attached hereto as Exhibit B.

            (iii) the Holder shall have obtained an opinion of its legal
counsel, addressed to the Company and reasonably acceptable to the Company,
stating that such Warrant Transfer complies with all applicable federal and
state securities laws; and

            (iv) the Holder shall only assign such rights and benefits pro rata
with the portion of the Warrant being transferred to the transferee.

      (b) The Holder agrees that it may not make a Warrant Transfer to:

            (i) any person that generated at least 20% of its total revenue (on
a consolidated basis together with all entities it controls, is controlled by,
or is under common control with) from government contracts in its last fiscal
year preceding the proposed Warrant Transfer, other than any Financial
Institution (as defined below), provided this limitation shall be waived with
respect to a proposed transferee if the Company determines in its reasonable
discretion that such proposed transferee does not then compete with the Company
or any entity controlled by the Company;

            (ii) any person or entity that is not a U.S. person. For this
purpose, U.S. persons shall be limited to those persons that (i) are defined as
U.S. persons in Section 7701(a)(3) of the Internal Revenue Code of 1986, as
amended (the "Code") and (ii) are U.S. citizens or entities organized under U.S.
federal or state laws which are not owned, controlled or influenced, directly or
indirectly, by a foreign person (or term of like meaning) under the National
Industrial Security Program Operating Manual (or any successor document) as
amended from time to time; or

            (iii) as long as the Company maintains its status as an
S-corporation within the meaning of Section 1361, et seq., of the Internal
Revenue Code of 1986, as amended, any person or entity whose ownership of the
Warrant or any portion thereof would cause the Company to lose such status.

      (c) INTENTIONALLY OMITTED.

                                       19
<PAGE>
      (d) Subject to the terms of Section 11 and subject to the restrictions set
out in Section 10(b), the Holder may transfer any number of Shares it has
obtained by exercising the Warrant or a portion thereof (a "Stock Transfer"),
provided that,

            (i) the Company is, at least fifteen (15) days prior to such Stock
Transfer, furnished with written notice of the name and address of the
transferee or assignee;

            (ii) the transferee agrees in writing to be bound by and subject to
the terms and conditions of this Agreement pursuant to the form of Assignment
and Joinder attached hereto as Exhibit B;

            (iii) the Holder shall have obtained an opinion of its legal
counsel, addressed to the Company and reasonably acceptable to the Company,
stating that such Stock Transfer complies with all applicable federal and state
securities laws; and

            (iv) the Holder shall only assign such rights and benefits pro rata
with the number of Shares being transferred to the transferee.

      (e) The Holder agrees that it may not make a Stock Transfer to:

            (i) any person that generated at least 20% of its total revenue (on
a consolidated basis together with all entities it controls, is controlled by,
or is under common control with) from government contracts in its last fiscal
year preceding the proposed Stock Transfer, other than any Financial Institution
(as defined below), provided this limitation shall be waived with respect to a
proposed transferee if the Company determines in its reasonable discretion that
such proposed transferee does not then compete with the Company or any entity
controlled by the Company;

            (ii) any person or entity that is not a U.S. person. For this
purpose, U.S. persons shall be limited to those persons that (i) are defined as
U.S. persons in Section 7701(a)(3) of the Internal Revenue Code of 1986, as
amended (the "Code") and (ii) are U.S. citizens or entities organized under U.S.
federal or state laws which are not owned, controlled or influenced, directly or
indirectly, by a foreign person (or term of like meaning) under the National
Industrial Security Program Operating Manual (or any successor document) as
amended from time to time; or

            (iii) as long as the Company maintains its status as an
S-corporation within the meaning of Section 1361, et seq., of the Internal
Revenue Code of 1986, as amended, any person or entity whose ownership of Common
Stock would cause the Company to lose such status.

      (f) Any transfer by the Holder that is in contravention of any of the
terms of Sections 10(a), (b), (d), or (e) above shall be void ab initio and of
no force or effect, and the Company shall not be obligated to honor or recognize
any such transfer on its stock records or otherwise.

      (g) "Financial Institution" shall mean any insurance company, bank, trust
company, pension fund (whether private, public or governmental), mutual fund or
any other entity whose primary business is owning and investing in the
securities of other unaffiliated entities, regardless of whether or not such
Financial Institution has an investment in a person or entity that generated at
least 20% of its total revenue from government contracts; provided that not

                                       20
<PAGE>
more than 50% of the Voting Stock of such Financial Institution is owned or
controlled, directly or indirectly, by a person or entity that generated at
least 20% of its total revenue from government contracts.

      Section 11. Company Right of First Refusal.

      (a) Before the Warrant, any portion thereof or any Shares may be sold or
otherwise transferred by the Holder, the Company shall have a right of first
refusal to purchase the Warrant, such portion thereof and/or any such Shares, as
the case may be, on the terms and conditions set forth in this Section 11.

      (b) If the Holder proposes to sell or otherwise transfer the Warrant, any
portion thereof or any number of the Shares it holds at such time to any third
party other than one that it controls, is controlled by, or is under common
control with (each an "Affiliate"), the Holder shall deliver to the Company a
written notice ("Sale Notice"), in accordance with Section 15, stating (i) the
Holder's bona fide intention to sell or otherwise transfer the Warrant, any
portion thereof or a certain number of Shares (collectively, the "Transfer
Interests"), as the case may be, (ii) the name of the proposed purchaser or
other transferee (the "Proposed Buyer"), and (iii) the bona fide cash price or
other consideration for which the Holder proposes to transfer the Transfer
Interests (the "Offered Price"), and the Holder shall offer to sell the Transfer
Interests to the Company at the Offered Price.

      (c) The Company may, at any time within sixty (60) days after receipt by
the Company of a Sale Notice, elect to purchase the Transfer Interests by giving
written notice to the Holder, in accordance with Section 15, at a purchase price
equal to the Offered Price (the "Purchase Price"). If the Offered Price includes
consideration other than cash, the cash equivalent value of the non-cash
consideration shall be determined by the board of directors of the Company in
good faith.

      (d) Payment of the Purchase Price shall be made in cash (by check) within
sixty (60) days after the date of the Company's election to purchase the
Transfer Interests.

      (e) If the Transfer Interests are not purchased by the Company as provided
herein, then the Holder may sell or otherwise transfer the Transfer Interests to
the Proposed Buyer at the Offered Price or at a higher price, provided that such
sale or other transfer (i) is consummated within six (6) months after the date
of the Sale Notice, and (ii) is in accordance with all the terms of this
Agreement and all other agreements between the Holder and the Company. If the
Transfer Interests are not transferred to the Proposed Buyer within such
six-month period in accordance with the preceding sentence, a new Sale Notice
shall be given to the Company, and the Company shall again be offered a right of
first refusal under this Section 11 before the Warrant, any portion thereof or
any Shares, as the case may be, may be sold or otherwise transferred.

      Section 12. INTENTIONALLY OMITTED.

                                       21
<PAGE>
      Section 13. Representations and Warranties and Covenants of The Holder.

      (a) Representations and Warranties. In order to induce the Company to
accept this Agreement, the Holder hereby represents and warrants to the Company
as follows:

            (i) Purchase Entirely for Own Account. The Holder represents that it
is acquiring the Warrant and the Shares issuable upon exercise of the Warrant
(collectively the "Securities") to be issued to it for investment for the
Holder's own account, not as a nominee or agent, and not with a view to view to
the resale or the distribution thereof, and that the Holder has no present
intention of selling, granting any participation rights in, or otherwise
distributing the same. By executing this Agreement, the Holder further
represents that the Holder does not have any contract, undertaking, agreement or
arrangement with any Person to sell, transfer or grant participations to such
Person or to any third Person, with respect to any of the Securities.

            (ii) Disclosure of Information. The Holder represents that it has
had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the sale of the Securities and the
business, properties, prospects and financial condition of the Company.

            (iii) Investment Experience. The Holder acknowledges that it can
bear the economic risk of its investment, and has such knowledge and experience
in financial or business matters that it is capable of evaluating the merits and
risks of the investment in the Securities. The Holder also represents it has not
been organized for the purpose of acquiring the Securities.

            (iv) Accredited Investor. The Holder is an "accredited investor"
within the meaning of Rule 501 of Regulation D promulgated under the Act, as
presently in effect.

            (v) Restricted Securities. The Holder understands that the Warrant
and the Shares it is purchasing are characterized as "restricted securities"
under the federal securities laws and applicable blue sky laws inasmuch as they
are being acquired from the Company in a transaction not involving a public
offering and that under such laws and applicable regulations such securities may
be resold without registration under the Securities Act and such blue sky laws
only in certain limited circumstances. In this connection, the Holder represents
that it is familiar with SEC Rule 144, as presently in effect, and understands
the resale limitations imposed thereby and by the Securities Act and such blue
sky laws.

            (vi) S-Corporation Shareholder. The Holder is an entity whose
ownership of Common Stock, if it were to exercise any portion of the Warrant on
the date hereof, would not cause the Company to lose its status as an
S-corporation within the meaning of Section 1361, et seq., of the Code (a
"Permitted S-corp Shareholder"). Notwithstanding any other provision of this
Agreement, the Holder shall not be entitled to exercise any portion of the
Warrant if its ownership of Common Stock would cause the Company to lose its
status as an S-corporation within the meaning of Section 1361, et seq., of the
Code.

      (b) Permitted S-corp Shareholder. In order to induce the Company to accept
this Agreement, the Holder covenants and agrees that it will not intentionally
or knowingly take any action to change its status from a Permitted S-corp
Shareholder (as defined above), which change

                                       22
<PAGE>
of status results in the Company losing its status as an S-corporation within
the meaning of Section 1361, et seq., of the Code.

      Section 14. Legends.

      It is understood that the certificates evidencing the Securities may bear
the following legends:

      (a) "THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR UNDER ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT AND UNDER ANY
RELEVANT STATE LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT
SUCH REGISTRATION IS NOT REQUIRED."

      (b) Any legend required by applicable state securities laws.

      (c) A legend to reflect restrictions on transferability of Common Stock
and warrants, to be contained in the Certificate of Incorporation of the
Company, as amended and restated, and/or the By-Laws of the Company, as amended
and restated.

      Section 15. Notices.

      Unless otherwise provided herein, any notice required or permitted under
this Agreement shall be given in writing and shall be delivered (a) by hand, (b)
by mail, certified mail, return receipt requested, or (c) by facsimile to the
party to be notified, at the address indicated for such party on the signature
page hereof, or at such other address as such party may designate by prior
written notice to the other party. Unless otherwise provided herein, notices
shall be deemed to have been given and served (a) where delivered by hand, at
time of delivery, (b) where delivered by mail, on acknowledgement of receipt as
shown by the date indicated on the return receipt as having been received, and
(c) where delivered by facsimile, 24 hours after transmission confirmation by
the transmitting machine unless within those 24 hours the intended recipient has
informed the sender that the transmission was received in an incomplete or
unreadable form, or the transmission report of the sender indicates a faulty or
incomplete transmission. If such receipt is on a day that is not a working day
or is later than 5 p.m. (local time) on a working day, the notice shall be
deemed to have been given and served on the next working day.

      Section 16. Covenants. So long as the Warrant remains outstanding:

      (a) As long as none of the clauses (a), (b) or (c) of the definition of
Current Market Price in Section 3(c)(ii) is applicable to the Common Stock, all
SARs issued by the Company will be issued with an exercise price no less than
the per share value of the Common Stock as set forth in the then most recent
appraisal performed by an independent appraiser at the Company's request in
connection with the ESOP. If one of the clauses (a), (b) or (c) of the
definition of Current Market Price in Section 3(c)(ii) is applicable to the
Common Stock, all SARs issued by the Company will be issued with an exercise
price no less than the then current Current Market Price. All SARs issued by the
Company will vest in accordance with the terms of the Company's

                                       23
<PAGE>
Stock Appreciation Rights Plan, as in effect at the time of issuance. The
Company will not issue SARs that cause the aggregate number of outstanding SARs
(excluding any SARs that have been exercised, that have expired, terminated
unexercised, or become unexercisable or that have been forfeited or otherwise
terminated, surrendered or cancelled), at the time of issuance, to be in excess
of:

                  (1) two percent (2%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the first anniversary of the Effective Date;

                  (2) four percent (4%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the second anniversary of the Effective Date;

                  (3) six percent (6%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the third anniversary of the Effective Date;

                  (4) eight percent (8%) of the number of then outstanding
shares of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the fourth anniversary of the Effective Date; and

                  (5) ten percent (10%) of the number of then outstanding shares
of Common Stock on a fully diluted basis (assuming the exercise of all
outstanding options, warrants and rights and the conversion into Common Stock of
all convertible securities) at the fifth anniversary of the Effective Date.

      (b) The Company will not issue Company Contributions that cause the
aggregate value of all Company Contributions to exceed, at the time of issuance,
five percent (5%) of the Company's aggregate consolidated payroll expenses
(i.e., the aggregate payroll expenses of the Company and of any of the Company's
Subsidiaries substantially all of whose employees are eligible to participate in
Company benefit plans) from the Effective Date to the date of such
contributions, measured at the end of each plan year for the Company benefit
plans.

      (c) The Company will not issue shares of phantom stock that cause the
number of shares of outstanding phantom stock (excluding any shares of phantom
stock that have expired, terminated unexercised, or become unexercisable, or
that have been forfeited or otherwise terminated, surrendered or cancelled), at
the time of issuance, to be in excess of 171,494 shares of phantom stock.

                                       24
<PAGE>
      Section 17. Rights and Obligations of the Trust.

      Notwithstanding anything contained herein to the contrary, the parties
hereto acknowledge and agree that the Trust shall only be a party to this
Agreement with respect to the terms and conditions contained in Sections 6, 7,
15, and 17 through 26, and shall not be liable for any obligations of the
Company hereunder.

      Section 18. Amendment.

      This Agreement may be amended by the mutual written agreement of the
Company and the Holder, except that Section 1, 6, 7, 15 and 17 through 26 of
this Agreement may only be amended by the mutual written consent of the Company,
the Trust and all holders of an outstanding portion of the Warrant.

      Section 19. Termination.

      This Warrant Agreement shall be terminated immediately upon the
termination of Crawford's employment by the Company for cause (as described in
Section 17.B of the Employment Agreement) or by Crawford without Good Reason (as
defined in Section 17.A of the Employment Agreement).

      Section 20. Binding Effect.

      This Agreement shall be binding upon and inure to the sole and exclusive
benefit of the Company and its successor, Crawford and his successors and the
Trust and its successors.

      Section 21. Governing Law.

      This Agreement shall be construed in accordance with and governed by the
laws of the State of Delaware, without regard to relevant conflict of law
principles.

      Section 22. Waiver.

      Failure to insist upon strict compliance with any of the terms, covenants
or conditions of this Agreement shall not be deemed a waiver of such terms,
covenants or conditions, nor shall any waiver or relinquishment of any right or
power hereunder at any one time or more times be deemed a waiver or
relinquishment of such right or power at any other time or times.

      Section 23. Entire Agreement.

      This Agreement constitutes the entire agreement between the parties hereto
with respect to the subject matter hereof and may be amended only by a writing
executed by all of the parties.

      Section 24. Severability.

      The invalidity or unenforceability of any provision of this Agreement
shall in no way affect the validity or enforceability of any other provision
hereof.

      Section 25. Headings.

                                       25
<PAGE>
      The headings to the sections of this Agreement are used for reference only
and are not to be construed as limiting or extending the provisions hereof.

      Section 26. Counterparts.

      This Agreement may be executed in any number of counterparts, each of
which shall be considered an original but all of which shall constitute the
Agreement by and among the parties.

                        [SIGNATURES FOLLOW ON NEXT PAGE]

                                       26
<PAGE>
      IN WITNESS WHEREOF, the parties hereto have caused this Alion Subordinated
Warrant Agreement to be executed under its corporate seal by its officers
thereunto duly authorized as of the date hereof.

ALION SCIENCE AND TECHNOLOGY CORPORATION

By:
   -------------------                         ---------------------------------
Name: Bahman Atefi                             Randy Crawford,
Title: Chief Executive Officer                 an individual
Address:          1750 Tysons Blvd.
                  Suite 1300
                  McLean, VA  22102-4213
Fax:              703-714-6508      Fax:

ALION SCIENCE AND TECHNOLOGY CORPORATION EMPLOYEE
OWNERSHIP, SAVINGS AND INVESTMENT TRUST,
FOR THE PURPOSES OF SECTIONS 6, 7, 15 AND 17 THROUGH 26
OF THIS SELLER WARRANT AGREEMENT ONLY

By:
   -----------------------------
Name:
Title: Trustee
Address:

Fax:

                                       27
<PAGE>
                                    EXHIBIT A

FORM OF EXERCISE NOTICE

(To be Executed by the Holder if the Holder Desires to Exercise the Warrant
Evidenced by the Foregoing Alion Subordinated Warrant Agreement)

To Alion Science and Technology Corporation

The undersigned hereby irrevocably elects to purchase ______ shares of Common
Stock, issuable upon exercise of said Warrant.

The undersigned hereby elects to make payment in connection with such exercise
by:

___ delivery of $_______ (in cash) and any applicable taxes payable by the
undersigned; or.

___ cashless exercise, pursuant to Section 2(c) of the Alion Subordinated
Warrant Agreement.

The undersigned requests that certificates for such shares be issued in the name
of

PLEASE INSERT TAX IDENTIFICATION NUMBER

---------------------------------------

---------------------------------------
(Print Name)

---------------------------------------
(Print Address)

---------------------------------------

                                       28
<PAGE>
                                    EXHIBIT B

                           ASSIGNMENT AND JOINDER FORM

      FOR VALUE RECEIVED, the undersigned Holder hereby sells, assigns and
transfers unto the undersigned Assignee all of the rights and obligations of the
undersigned Holder under the within Alion Subordinated Warrant Agreement, with
respect to _________ shares of Common Stock (the "Warrant Shares"), and does
hereby irrevocably constitute and appoint ________ to make such transfer on the
books of the Company maintained for the purpose, with full power of substitution
in the premises.

      The Assignee hereby acknowledges and agrees that (i) it is assuming all of
the obligations, relating to the portion of the Warrant being assigned and
transferred pursuant to this instrument (the "Warrant Portion") and the Warrant
Shares, which are contained in the Alion Subordinated Warrant Agreement, and
(ii) as of the date written below, the Assignee shall join and become a party to
the Alion Subordinated Warrant Agreement as if it were named on the signature
page of the Alion Subordinated Warrant Agreement as a Holder and that it shall
be bound as a Holder by all of the terms, conditions, covenants and restrictions
contained in the Alion Subordinated Warrant Agreement.

      The undersigned Holder and Assignee hereby agree that this instrument
shall be construed in accordance with and governed by the laws of the State of
Delaware, without regard to relevant conflict of law principles.

Dated:
                                               HOLDER

                                               By:
                                                  ------------------------------
                                               Name:
                                               Its:

                                               ASSIGNEE

                                               By:
                                                  ------------------------------
                                               Name:
                                               Its:

                                       29exv10w28

 

EXHIBIT 10.28

Alion Subordinated Deferred Compensation Agreement

     This deferred compensation agreement (“the Agreement”), effective
_________________, 2002 by and between Alion Science and Technology Corporation,
a Delaware corporation (“Alion”) and Stacy Mendler (“Participant”) is intended
to establish a plan of nonqualified deferred compensation in order to provide
Participant with a degree of retirement income security and to encourage
Participant to provide continued services to Alion.

WITNESSETH:

WHEREAS, Participant is a member of a select group of management and highly
compensated employees of Alion; and

WHEREAS, it is the intent of the parties to have this Agreement be a plan of
nonqualified deferred compensation within the meaning of the Internal Revenue
Code of 1986, as amended;

NOW, THEREFORE, Alion and the Participant hereby agree that the following shall
be the terms, provisions, conditions and covenants of this Agreement, effective ___________
2002.

	1.	 	Purpose of Agreement. The Agreement shall serve as a nonqualified
deferred compensation plan to benefit the selected executive. The plan is
intended to be an unfunded “top hat” pension plan under the Employee
Retirement Income Security Act of 1974.
	 
	2.	 	Participant. The sole Participant of this Agreement shall be Stacy
Mendler, who shall become a Participant upon execution of this Agreement.
	 
	3.	 	Plan Administrator. That person or persons designated from time to time
by the Board of Directors of Alion (“the Board”).
	 
	4.	 	Deferred Compensation Account. Alion shall credit to a book reserve (the
“Deferred Compensation Account”) established for this purpose, $300,000
on ___________, 2002.
	 
	5.	 	Plan Year. Each respective twelve-month period commencing on the effective date of this agreement, and ending on the one-year anniversary thereafter.

1

 

	6.	 	Crediting of Earnings for Deferred Compensation Account. For the Plan
Years commencing _______________, 2002 and ending _______________, 2008, the principal amount of
Participant’s Deferred Compensation Account shall be credited quarterly by
the Plan Administrator based on a fixed 6% annual rate of
notional interest as though (i) Participant’s Deferred Compensation
Account were invested in a fixed interest bearing investment account; and
(ii) any distribution made to the Participant that decreases the
Participant’s Deferred Compensation Account ceased being invested in this
interest bearing account as soon as administratively possible. For the
Plan Years commencing _______________, 2008 and ending _______________, 2010, the Participant’s Deferred
Compensation Account shall be credited quarterly by the Plan Administrator
based on a fixed 16% annual rate of notional interest in this
same manner.
	 
	7.	 	Investment of Deferred Compensation Account. Any amount credited to the
Deferred Compensation Account may be kept in cash or invested and
reinvested by Alion in mutual funds, stocks, bonds, securities or any
other assets as may be selected by the Board in its discretion in order to
satisfy the obligation to Participant. In the exercise of the foregoing
discretionary investment powers, the Board may engage investment counsel
and, if it so desires, may delegate to such counsel full or limited
authority to select the assets in which the funds are to be invested.
	 
	8.	 	Creation of a Trust. The Board, in its sole discretion, may establish a
trust that shall remain subject to the claims of Alion’s creditors. Upon
creation of such trust, Alion shall contribute to the trust an amount
equal to the amount credited to the Participant’s Deferred Compensation
Account. The investment of trust assets shall be performed in accordance
with Section 6 of this Agreement.
	 
	9.	 	No Rights in Deferred Compensation Account or Trust. In the event that
Alion or the trustee (as that term is defined in the trust), in its own
discretion, decides to invest the amounts recorded in the Deferred
Compensation Account or contributed to the trust, Participant shall have
no rights in or to such investments themselves. Without limiting the
foregoing, the Participant’s Deferred Compensation Account shall at all
times be a bookkeeping entry only and shall not represent any investment
made on his behalf by Alion or the trust and the Participant shall at all
times remain an unsecured creditor of Alion.

2

 

	10.	 	Payment of Deferred Compensation.

	 	(i)	 	Distributions: If Participant is employed by Alion at the end of
the Plan Year ___________, 2009, then Participant shall receive a lump sum
distribution equal to 50% of his Deferred Compensation Account on that
date. If Participant is employed by Alion at the end of the Plan Year ___________, 2010, then Participant shall receive a lump sum distribution of the
remainder of Participant’s Deferred Compensation Account.
If and to the extent that the series of subordinated notes issued by Alion in
conjunction with the purchase of substantially all of the assets of IIT Research
Institute are paid off prior to the scheduled distribution date, the
Participant’s deemed investment in such subordinated notes shall
be proportionately deemed paid off and the rates of
interest identified in Section 6 shall thereafter be adjusted for the deemed investment
experience of other deemed investment options made available under the terms of
the Alion Deferred Compensation Plan pending vesting and payment in
accordance with this Agreement.
These lump sum distributions shall be paid to Participant within 30 days of
Participant’s satisfaction of the above-referenced service
requirements.
	 
	 	(ii)	 	Voluntary Termination: If Participant voluntarily terminates
employment with Alion prior to either of the dates listed in (i) above
then Participant shall forfeit all rights in any unpaid amounts of his
Deferred Compensation Account, unless such termination is for Good
Reason, (as defined by Section 17.A of Participant’s Employment
Agreement but for this purpose only, without regard to whether the
occurrence of one of the events is during the Protected Period, as
defined by the Employment Agreement). If Participant voluntarily
terminates employment with Alion for Good Reason, then Participant
shall immediately vest in a prorated portion of his Deferred
Compensation Account based on a ratio the numerator of which is the
number of months from the Effective Date of this Agreement through the
end of the month of such termination and the denominator of which is
96. Payment of such vested amount shall be made within 30 days of the
date of termination.
	 
	 	(iii)	 	Involuntary Termination other than for Cause: If the Participant
is involuntarily terminated from employment with Alion for any reason
other than Just Cause, then he shall immediately vest in a prorated
portion of his Deferred Compensation Account. The prorated vesting
shall be based on a ratio, the numerator of which is the number of
months from the Effective Date of this Agreement through the end of the
month of such termination and the denominator of which is 96. Payment
of such vested amount shall be made within 30 days of the date of
termination. For these purposes, Just Cause shall mean, (i)
Participant’s material breach of his Employment Agreement which is not
cured within thirty (30) days after receipt of notice thereof; (ii)
Participant’s theft or embezzlement of any material property of Alion;
(iii) Participant’s gross negligence or willful misconduct in
performing his duties under his Employment Agreement; (iv)
Participant’s willful refusal to perform or substantial neglect of any
duties under his Employment Agreement; (v) Participant’s unauthorized
use of Alion’s trade secrets or Proprietary Information (as defined by
Section 21 of his Employment Agreement); (vi) Participant’s commission
of a felony which adversely affects Alion’s business, reputation or
business relations. If Participant is terminated for Just Cause,
Participant shall not be entitled to any future payments of unpaid
amounts of his Deferred Compensation Account.

3

 

	11.	 	Reporting. From time to time, not less often than quarterly, the Plan
Administrator shall provide to Participant an accounting of assets,
income, gain and loss in the Participant’s Deferred Compensation Account.
Unless waived by the Participant, upon termination of the Deferred
Compensation Account, the Plan Administrator shall make an accounting
available to Participant.
	 
	12.	 	Nonalienation of Benefits. The right of the Participant or any other
person to the payment of deferred compensation or other benefits under
this Agreement shall not be assigned, transferred, pledged or encumbered
except by will or by the laws of descent and distribution.
	 
	13.	 	Withholding. Alion, or the trustee of the trust, shall withhold from any
distributions made to Participant under this Agreement all federal, state
and local income, employment and other taxes required to be withheld by
Alion, or the trustee of the trust, in connection with such distributions,
in amounts and in a manner to be determined in the sole discretion of
Alion and the trustee of the trust.
	 
	14.	 	No Rights to Continued Employment. Nothing contained herein shall be
construed as conferring upon the Participant the right to continue in the
employ of Alion as an executive or in any other capacity.
	 
	15.	 	Deferred Compensation not Benefit Bearing. Any deferred compensation
payable under this Agreement shall not be deemed salary or other
compensation to the Participant for the purpose of computing benefits to
which he may be entitled under any pension plan or other arrangement of
Alion for the benefit of its employees.
	 
	16.	 	Interpretation of Agreement. The Board shall have full power and
authority to interpret, construe, and administer this Agreement and the
Board’s interpretations and construction thereof, and actions thereunder,
including any valuation of the Deferred Compensation Account, or the
amount or recipient of the payment to be made therefrom, shall be binding
and conclusive on all persons for all purposes. No member of the Board
shall be liable to any person for any action taken or omitted in
connection with the interpretation and administration of this Agreement
unless attributable to his own willful misconduct or lack of good faith.
	 
	17.	 	Agreement Binding on Successors. This agreement shall be binding upon
and inure to the benefit of Alion, its successors and assigns, and the
Participant and his heirs, executors, administrators, and legal
representatives.

4

 

	18.	 	Warrant Agreement. Participant has received a grant of warrants equal to
______% of Alion’s common stock outstanding on the closing date of the acquisition. These warrants have been granted
under a separate agreement between Alion and Participant, and such warrant
agreement is not affected by this Agreement.
	 
	19.	 	Governing Law. This Agreement shall be construed in accordance with and
governed by the laws of the Commonwealth of Virginia.
	 
	20.	 	Severability. If any provision of this Agreement is found, held or
deemed to be void, unlawful or unenforceable under any applicable statute
or other controlling law, the remainder of this Agreement shall continue
in full force and effect.

In WITNESS WHEREOF, Alion has caused this Agreement to be executed by its duly
authorized officers and Participant has hereunto set his hand and seal as of
the date first above written.

	 	 	 
	Stacy Mendler, Participant	 	
Alion Science and Technology Corporation, a

Delaware Corporation
	 
	     	 	
By:     
	
		

	
 

			

	 	 	
Title

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}]]